Research |
![]() ![]() ![]() ![]() ![]() |
Serial Number | 87025103 |
Registration Number | 5633325 |
Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
Attorney Name | R.J. Heher |
Attorney Docket Number | 29160-00070 |
Law Office Assigned | N20 |
Employee Name | O'BRIEN, JENNIFER LYNN |
2016-05-04 | Application Filed |
2017-05-30 | Published for Opposition |
2018-07-18 | Date of First Use |
2018-11-15 | Location: PUBLICATION AND ISSUE SECTION |
2018-12-18 | Status: Live/Registered |
2018-12-18 | Trademark Registered |
2019-08-08 | Transaction Date |
Owner: | ![]() |
Address | 20451 Seneca Meadows Parkway Germantown MD 20876 |
Legal Entity Type | Corporation |
Legal Entity State | MD |
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
International Codes: | 9 |
U.S. Codes: | 021,023,026,036,038 |
Type Code | Type |
---|---|
GS0091 | Computer application software for mobile phones, handheld computers, desktop computers, laptop computers, namely, software for recording, analyzing, reporting, managing and accessing patient glucose levels and patient health and medical information; Computer application software for mobile phones, handheld computers, desktop computers, laptop computers, namely, software for third parties to access patient glucose levels and patient health and medical information; downloadable cloud computer software for third parties to access patient glucose levels and patient health and medical information; downloadable cloud computer software recording, analyzing, reporting, managing and accessing patient glucose levels and patient health and medical information; Computer software for use with glucose sensors, namely, software for recording, analyzing, reporting and managing patient glucose levels; computer software for recording, analyzing, reporting and managing patient health and medical information; downloadable software in the nature of a desktop or mobile application for use in the electronic transmission of patient health and medical information; downloadable computer software for use in the electronic transmission of patient glucose levels, related glucose level data and patient health and medical information |
Description | Date | Event Coding |
---|---|---|
NEW APPLICATION ENTERED IN TRAM | 2016-05-07 | 1 NWAP I:Incoming Correspondence |
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2016-05-09 | 2 NWOS I:Incoming Correspondence |
NOTICE OF PSEUDO MARK E-MAILED | 2016-05-10 | 3 MPMK E:E-Mail |
ASSIGNED TO EXAMINER | 2016-08-19 | 4 DOCK D:Assigned to Examiner |
SUSPENSION LETTER WRITTEN | 2016-08-22 | 5 CNSL R:Renewal |
LETTER OF SUSPENSION E-MAILED | 2016-08-22 | 6 GNSL F:First Action |
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | 2016-08-22 | 7 GNS3 O:Outgoing Correspondence |
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | 2017-02-21 | 8 ERSI I:Incoming Correspondence |
ASSIGNED TO LIE | 2017-03-09 | 9 ALIE A:Allowance for Publication |
CORRESPONDENCE RECEIVED IN LAW OFFICE | 2017-03-15 | 10 CRFA I:Incoming Correspondence |
TEAS/EMAIL CORRESPONDENCE ENTERED | 2017-03-15 | 11 TEME I:Incoming Correspondence |
APPROVED FOR PUB - PRINCIPAL REGISTER | 2017-04-06 | 12 CNSA P: |
LAW OFFICE PUBLICATION REVIEW COMPLETED | 2017-04-21 | 13 PREV O:Outgoing Correspondence |
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2017-05-10 | 14 NONP E:E-Mail |
PUBLISHED FOR OPPOSITION | 2017-05-30 | 15 PUBO A:Allowance for Publication |
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2017-05-30 | 16 NPUB E:E-Mail |
NOA E-MAILED - SOU REQUIRED FROM APPLICANT | 2017-07-25 | 17 NOAM E:E-Mail |
TEAS EXTENSION RECEIVED | 2018-01-22 | 18 EEXT I:Incoming Correspondence |
EXTENSION 1 FILED | 2018-01-22 | 19 EXT1 S: |
EXTENSION 1 GRANTED | 2018-01-22 | 20 EX1G S: |
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2018-01-24 | 21 EXRA E:E-Mail |
ASSIGNED TO EXAMINER | 2018-06-01 | 22 DOCK D:Assigned to Examiner |
TEAS EXTENSION RECEIVED | 2018-07-05 | 23 EEXT I:Incoming Correspondence |
EXTENSION 2 FILED | 2018-07-05 | 24 EXT2 S: |
EXTENSION 2 GRANTED | 2018-07-05 | 25 EX2G S: |
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2018-07-07 | 26 EXRA E:E-Mail |
TEAS STATEMENT OF USE RECEIVED | 2018-09-27 | 27 EISU I:Incoming Correspondence |
CASE ASSIGNED TO INTENT TO USE PARALEGAL | 2018-10-23 | 28 AITU A:Allowance for Publication |
USE AMENDMENT FILED | 2018-09-27 | 29 IUAF S: |
STATEMENT OF USE PROCESSING COMPLETE | 2018-10-24 | 30 SUPC I:Incoming Correspondence |
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | 2018-11-15 | 31 CNPR P: |
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | 2018-11-16 | 32 SUNA E:E-Mail |
REGISTERED-PRINCIPAL REGISTER | 2018-12-18 | 33 R.PR A:Allowance for Publication |
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | 2019-08-07 | 34 ASCK I:Incoming Correspondence |
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | 2020-04-29 | 35 ASCK I:Incoming Correspondence |
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | 2020-09-02 | 36 ASCK I:Incoming Correspondence |
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | 2020-09-09 | 37 ASCK I:Incoming Correspondence |
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | 2023-12-18 | 38 REM1 E:E-Mail |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.